News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,347 Results
Type
Article (88909)
Company Profile (724)
Press Release (795695)
Multimedia
Podcasts (243)
Webinars (36)
Section
Business (233646)
Career Advice (4164)
Deals (40018)
Drug Delivery (181)
Drug Development (91767)
Employer Resources (207)
FDA (18591)
Job Trends (17495)
News (398861)
Policy (40022)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (211)
Alliances (56990)
ALS (242)
Alzheimer's disease (1996)
Antibody-drug conjugate (ADC) (583)
Approvals (18979)
Artificial intelligence (904)
ASCO (345)
Autoimmune disease (381)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (78)
BIOSECURE Act (23)
Biosimilars (256)
Biotechnology (432)
Bladder cancer (215)
Brain cancer (86)
Breast cancer (857)
Cancer (6763)
Cardiovascular disease (570)
Career advice (3601)
Career pathing (53)
CAR-T (393)
CDC (77)
Celiac Disease (3)
Cell therapy (1101)
Cervical cancer (58)
Clinical research (79315)
Collaboration (2443)
Commercialization (1)
Company closure (8)
Compensation (1576)
Complete response letters (110)
COVID-19 (3044)
CRISPR (128)
C-suite (1343)
Cystic fibrosis (169)
Data (8929)
Decentralized trials (3)
Denatured (93)
Depression (202)
Dermatology (101)
Diabetes (722)
Diagnostics (7632)
Digital health (72)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (458)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (331)
Earnings (102543)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (138938)
Executive appointments (1221)
FDA (22826)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (2011)
Gene editing (279)
Generative AI (92)
Gene therapy (867)
GLP-1 (1296)
Government (5570)
Grass and pollen (8)
Guidances (426)
Healthcare (21272)
Hematology (198)
HIV (100)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (118)
Immunology and inflammation (365)
Immuno-oncology (121)
Indications (225)
Infectious disease (3452)
Inflammatory bowel disease (246)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (332)
Interviews (822)
IPO (18010)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (24)
Labor market (126)
Layoffs (694)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (891)
Lymphoma (488)
Machine learning (70)
Management (68)
Manufacturing (1287)
Marketing (4)
MASH (231)
Medical affairs (1)
Medical device (15304)
Medtech (15488)
Mergers & acquisitions (23354)
Metabolic disorders (1865)
mRNA (277)
Multiple sclerosis (211)
NASH (24)
Neurodegenerative disease (527)
Neuropsychiatric disorders (132)
Neuroscience (3801)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5147)
Now hiring (84)
Obesity (886)
Opinion (381)
Ovarian cancer (251)
Pain (289)
Pancreatic cancer (374)
Parkinson's disease (429)
Partnered (42)
Patents (680)
Patient recruitment (812)
Peanut (72)
People (68162)
Pharmaceutical (115)
Pharmacy benefit managers (38)
Phase 1 (24511)
Phase 2 (34455)
Phase 3 (25905)
Pipeline (10215)
Policy (405)
Postmarket research (3560)
Preclinical (11003)
Press Release (72)
Prostate cancer (355)
Psychedelics (73)
Radiopharmaceuticals (378)
Rare diseases (1325)
Real estate (7463)
Recruiting (82)
Regulatory (30627)
Reports (77)
Research institute (2776)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (198)
Series A (344)
Series B (251)
Service/supplier (24)
Sickle cell disease (132)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4376)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (147)
Vaccines (1334)
Venture capital (142)
Weight loss (605)
Women's health (147)
Worklife (25)
Date
Today (26)
Last 7 days (478)
Last 30 days (2212)
Last 365 days (33168)
2026 (17803)
2025 (33217)
2024 (38031)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (101)
Alaska (7)
Arizona (410)
Arkansas (16)
Asia (52420)
Australia (9211)
California (14641)
Canada (4108)
China (1638)
Colorado (630)
Connecticut (650)
Delaware (453)
Europe (120880)
Florida (2192)
Georgia (475)
Hawaii (4)
Idaho (70)
Illinois (1286)
India (107)
Indiana (673)
Iowa (27)
Japan (624)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1770)
Massachusetts (10728)
Michigan (428)
Minnesota (817)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (157)
New Hampshire (92)
New Jersey (3879)
New Mexico (35)
New York (3868)
North Carolina (1964)
North Dakota (11)
Northern California (7305)
Ohio (460)
Oklahoma (27)
Oregon (55)
Pennsylvania (2872)
Puerto Rico (33)
Rhode Island (55)
South America (1669)
South Carolina (89)
South Dakota (2)
Southern California (5762)
Tennessee (240)
Texas (2393)
United States (52395)
Utah (438)
Vermont (2)
Virginia (377)
Washington D.C. (89)
Washington State (1195)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
There are 885,347 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Genentech’s June layoffs hit 103 employees at California HQ
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
July 6, 2026
·
66 min read
·
BioSpace Editorial Staff
IPO
Early-stage Scribe wants to write IPO story even as investors favor derisked portfolios
Scribe Therapeutics’ pipeline is immature, with its lead program recently greenlit for first-in-human testing. The biotech is working on CRISPR-based therapies for cardiometabolic diseases.
July 6, 2026
·
2 min read
·
Tristan Manalac
Deals
Novartis drops up to $1.5B for ADC specialist Myricx, continuing cancer spending spree
The centerpiece of the acquisition is Myricx Bio’s novel N-myristoyltransferase inhibitor payload platform, which could help Novartis develop antibody-drug conjugates that can overcome the limitations of existing therapies.
July 6, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
BridgeBio touts kidney benefits for Attruby, differentiating from amyloidosis competitors
BridgeBio’s Attruby preserves kidney function in patients with transthyretin amyloidosis cardiomyopathy, an effect that is “distinct” from other drugs in this space, according to Jefferies.
July 6, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Alzheon to Present New Evidence of Neurovascular Protection and Preserved Brain Microstructure from Oral Valiltramiprosate Trials in APOE4/4 Alzheimer’s Patients at AAIC 2026 Conference in London
July 6, 2026
·
13 min read
Press Releases
Signatera™ MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer
July 6, 2026
·
4 min read
Press Releases
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
July 6, 2026
·
9 min read
Press Releases
AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder
July 6, 2026
·
9 min read
Press Releases
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
July 6, 2026
·
9 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - July 6, 2026
July 6, 2026
·
2 min read
1 of 88,535
Next
